BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 16, 2004
View Archived Issues
Sphingosine kinase type 2 involved in phosphorylation of immunosuppressant FTY-720
Read More
Significant improvements reported with atorvastatin in NASH
Read More
FluMist reported to protect healthy children against natural influenza infection
Read More
Nolomirole attenuates heart failure
Read More
In vivo attenuation of nonseptic shock by superoxide dismutase mimetic M-40401
Read More
DA-8159 effective for inducing erection in rabbit models of spinal cord injury
Read More
Lorus Therapeutics makes solid progress in advanced clinical programs during 1H of fiscal 2004
Read More
Drug candidates from lead programs at Rigel enter clinic in 2003
Read More
Pharmacyclics broadens clinical development of Xcytrin during Q2
Read More
Gilead announces year-end 2003 product pipeline highlights
Read More
Array BioPharma signs two important agreements during Q2 FY2004
Read More
CEP-1347 reported well tolerated in Parkinson's disease patients
Read More
Preliminary analysis of phase I Oxycyte study
Read More
Estrogel receives FDA approval
Read More
Melanotan implant study produces encouraging results
Read More
Two series of antibacterial oxazolidinones recently designed at Pharmacia
Read More
NitroMed claims new NO-releasing COX-2 inhibitors
Read More
Novel antitumor agents in early development at Zentaris
Read More
New antiobesity MCH antagonists developed by Schering-Plough researchers
Read More
Novel beta-secretase inhibitors emerge from Actelion R&D
Read More
Merck & Isis collaboration yields novel HCV NS5B inhibitors
Read More
Novo Nordisk claims novel glucagon receptor inhibitors and their use
Read More
New prodrugs of thrombin inhibitors covered by LG Life Sciences patent
Read More
E-2000 Japanese NDA withdrawn
Read More
PRX-00023 enters clinical testing
Read More
Ultrafine completes manufacture to GMP of ATI-2042
Read More
Approval for generic formulations of Lotensin
Read More
First phase of Dermicol testing completed
Read More
Tularik advances T-71 into phase I
Read More
Valeant to acquire Amarin U.S. operations
Read More
New phase II study for MT-201 in prostate cancer
Read More